Pacer Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Pacer Advisors's LMAT Position: Q1 2026 in Review
Pacer Advisors increased its LeMaitre Vascular (LMAT) stake by 46% in Q1 2026, buying an estimated $64.9K and bringing the position to 2,172 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.
Pacer Advisors first reported a position in LMAT in Q2 2023 and has held it in 11 quarters since. The position peaked at $272K in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Pacer Advisors held 2,172 shares of LeMaitre Vascular worth $237K as of Q1 2026.
- Pacer Advisors bought 681 LeMaitre Vascular shares in Q1 2026, an estimated $64.9K.
- LeMaitre Vascular made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1709 holding.
- Pacer Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 11 quarters since.
- Pacer Advisors's LeMaitre Vascular position peaked at $272K in Q4 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.